We are live on ! Find out more
CCM

CAAS Capital Management Portfolio holdings

AUM $934M
1-Year Est. Return 1.45%
This Fund
S&P 500
This Quarter Est. Return
+26.63%
1 Year Est. Return
+1.45%
3 Year Est. Return
+10.99%
5 Year Est. Return
+150.62%
10 Year Est. Return
–
AUM
$10.5B
AUM Growth
+$6.2B
Cap. Flow
+$4.78B
Cap. Flow %
45.54%
Top 10 Hldgs %
28.07%
Holding
985
New
521
Increased
87
Reduced
60
Closed
171

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$153M
2
RUN icon
Sunrun
RUN
+$94.3M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$83.8M
4
DT icon
Dynatrace
DT
+$67.2M
5
ED icon
Consolidated Edison
ED
+$56.8M

Top Sells

Rank Stock Value
1
FSLR icon
First Solar
FSLR
+$71.8M
2
TXG icon
10x Genomics
TXG
+$62.3M
3
CZR icon
Caesars Entertainment
CZR
+$60.8M
4
DNLI icon
Denali Therapeutics
DNLI
+$53.1M
5
PENN icon
PENN Entertainment
PENN
+$42M

Sector Composition

Rank Sector Weight
1 Technology 7.01%
2 Healthcare 6.25%
3 Communication Services 2.7%
4 Consumer Discretionary 2.07%
5 Financials 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MMM icon
626
3M
MMM
$93.6B
$839K 0.01%
+5,741
New +$815K
PTRA
627
DELISTED
Proterra Inc. Common Stock
PTRA
$831K 0.01%
+75,000
New +$782K
MRVL icon
628
Marvell Technology
MRVL
$196B
$830K 0.01%
+17,450
New +$755K
TARS icon
629
Tarsus Pharmaceuticals
TARS
$2.67B
$827K 0.01%
+20,000
New +$570K
KURA icon
630
CALL
Kura Oncology
KURA
$841M
$817K 0.01%
+25,000
New +$878K
TSHA icon
631
Taysha Gene Therapies
TSHA
$1.78B
$796K 0.01%
30,000
– –
CALA
632
PUT
DELISTED
Calithera Biosciences, Inc
CALA
$786K 0.01%
+8,000
New +$701K
BC icon
633
CALL
Brunswick
BC
$5.41B
$778K 0.01%
+10,200
New +$720K
MUDSU
634
DELISTED
Mudrick Capital Acquisition Corporation II Unit
MUDSU
$773K 0.01%
+75,000
New +$764K
SBG.U
635
DELISTED
Sandbridge Acquisition Corporation Units, each consisting of one share of Class A Common Stock and o
SBG.U
$773K 0.01%
75,000
– –
SWI
636
CALL
DELISTED
SolarWinds Corporation Common Stock
SWI
$748K 0.01%
+47,400
New +$1.04M
BP icon
637
BP
BP
$109B
$739K 0.01%
36,000
-18,115
-33% -$341K
XLNX
638
PUT
DELISTED
Xilinx Inc
XLNX
$737K 0.01%
5,200
– –
HZNP
639
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$732K 0.01%
+10,000
New +$743K
BSX icon
640
Boston Scientific
BSX
$71.1B
$712K 0.01%
+19,800
New +$714K
LVS icon
641
Las Vegas Sands
LVS
$29.8B
$703K 0.01%
11,800
– –
DGNR.U
642
DELISTED
Dragoneer Growth Opportunities Corp. Units, each consisting of one Class A ordinary share, and one-f
DGNR.U
$700K 0.01%
50,000
– –
FOLD
643
CALL
DELISTED
Amicus Therapeutics
FOLD
$693K 0.01%
+30,000
New +$614K
PLUG icon
644
PUT
Plug Power
PLUG
$3.01B
$682K 0.01%
20,100
– –
MSI icon
645
PUT
Motorola Solutions
MSI
$73.5B
$680K 0.01%
+4,000
New +$671K
TPGY.U
646
DELISTED
TPG Pace Beneficial Finance Corp. Units, each consisting of one Class A ordinary share and one-fifth of one redeemable warrant
TPGY.U
$680K 0.01%
+25,000
New +$355K
DFS
647
DELISTED
Discover Financial Services
DFS
$652K 0.01%
+7,200
New +$537K
MRACU
648
DELISTED
Marquee Raine Acquisition Corp. Unit
MRACU
$650K 0.01%
+60,000
New +$641K
EOG icon
649
EOG Resources
EOG
$76.4B
$643K 0.01%
+12,900
New +$561K
ZNGA
650
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$642K 0.01%
+65,000
New +$585K
24 25
26
27 28

Similar funds

CIG
CCM Investment Group Northfield, Minnesota $946M AUM
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
SWC
Spectrum Wealth Counsel Indianapolis, Indiana $833M AUM 10.83% 1-Year Est. Return
KTA
Keeley-Teton Advisors Chicago, Illinois $825M AUM 5.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return

CAAS Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, CAAS Capital Management held 985 positions worth $10.5B, up 145% from $4.29B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

CAAS Capital Management deployed $4.78B of net new capital in Q4 2020, opening 521 new positions and adding to 87 existing holdings. Its largest new stake was Sunrun: 1,519,346 shares worth $105M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.8% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was First Solar, an estimated $71.8M trimmed.

  • CAAS Capital Management's largest Q4 2020 buy was Sunrun: 1,519,346 shares worth $105M.
  • CAAS Capital Management added most to Royalty Pharma in Q4 2020, an estimated $153M increase.
  • CAAS Capital Management's biggest Q4 2020 reduction was First Solar, cutting an estimated $71.8M.
  • CAAS Capital Management fully exited 10x Genomics in Q4 2020, selling an estimated $62.3M.
  • CAAS Capital Management's ten largest holdings make up 28% of its $10.5B portfolio in Q4 2020.
  • CAAS Capital Management opened 521 new positions and closed 171 in Q4 2020.
  • CAAS Capital Management's portfolio value rose 145% quarter-over-quarter to $10.5B.

Based on CAAS Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.